United Therapeutics | Zinsaufwendungen Für Schuld



Interest Expense On Debt Veränderung Datum
Amarin USD 0 8K 2024-06
Ardelyx USD 3.97M 610K 2024-12
Baxter International USD 100M 1000K 2024-12
Bayer 703M 61M 2024-12
Biogen USD 60M 200K 2024-12
BioMarin Pharmaceutical USD 2.58M 391K 2024-12
Gilead Sciences USD 248M 10M 2024-12
GlaxoSmithKline 173M 17M 2024-12
Halozyme Therapeutics USD 4.54M 16K 2024-12
Insmed USD 19.8M 532K 2024-12
Intra Cellular Therapies 5.97M 966K 2023-12
Ionis Pharmaceuticals USD 2.59M 70K 2024-12
J&J USD 137M 56M 2024-12
Moderna USD 6M 0 2024-12
Pfizer USD 739M 45M 2024-12
PTC Therapeutics USD 42.11M 1.09M 2024-09
Regeneron Pharmaceuticals USD 10.5M 3.3M 2024-12
Sarepta Therapeutics USD 4.92M 86K 2024-09
Teva Pharmaceutical Industries USD 224M 1000K 2024-12
United Therapeutics USD 7.9M 2.2M 2024-12
Vertex Pharmaceuticals USD 2.8M 4.7M 2024-12



United Therapeutics Zinsaufwendungen Für Schuld - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - Mar 2025.